Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Baylor College of Medicine
Baylor College of Medicine
Pilatus Biosciences Inc
Seattle Children's Hospital
Angiex, Inc.
Baylor College of Medicine
University Health Network, Toronto
Coherus Oncology, Inc.
MacroGenics
National Institutes of Health Clinical Center (CC)
Novita Pharmaceuticals, Inc.
Celldex Therapeutics
Columbia University
Xencor, Inc.
Pfizer
Pfizer
Celldex Therapeutics
Zhejiang University
Celldex Therapeutics
Xencor, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Zhujiang Hospital
University of Chicago
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Duke University
AEterna Zentaris
University of Chicago
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mannkind Corporation
Envita Medical Center, Inc.
NS Pharma, Inc.